N
Nira Ben-Jonathan
Researcher at University of Cincinnati
Publications - 100
Citations - 8240
Nira Ben-Jonathan is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Prolactin & Adipose tissue. The author has an hindex of 41, co-authored 99 publications receiving 7771 citations. Previous affiliations of Nira Ben-Jonathan include University of Western Australia & University of Cincinnati Academic Health Center.
Papers
More filters
Journal ArticleDOI
Dopamine as a prolactin (PRL) inhibitor.
Nira Ben-Jonathan,Robert Hnasko +1 more
TL;DR: PRL homeostasis should be viewed in the context of a fine balance between the action of dopamine as an inhibitor and the many hypothalamic, systemic, and local factors acting as stimulators, none of which has yet emerged as a primary PRL releasing factor.
Journal ArticleDOI
Extrapituitary Prolactin: Distribution, Regulation, Functions, and Clinical Aspects*
TL;DR: This review addresses the concept of the dual function of PRL, as a circulating hormone and a cytokine, based on its shared properties with hematopoietic growth factors.
Journal ArticleDOI
The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo
TL;DR: BPA mimics estradiol in inducing hyperprolactinemia in genetically predisposed rats and the in vivo action is mediated, at least in part, by increasing PRL regulating factor activity in the posterior pituitary.
Journal ArticleDOI
What can we learn from rodents about prolactin in humans
TL;DR: There is sufficient disparity in the control of the production, distribution, and physiological functions of PRL among these species to warrant careful and judicial extrapolation to humans.
Journal ArticleDOI
Bisphenol A at Environmentally Relevant Doses Inhibits Adiponectin Release from Human Adipose Tissue Explants and Adipocytes
Eric R. Hugo,Terry D. Brandebourg,Jessica G. Woo,Jean Loftus,J. Wesley Alexander,Nira Ben-Jonathan +5 more
TL;DR: BPA at environmentally relevant doses inhibits the release of a key adipokine that protects humans from metabolic syndrome, and the mechanism by which BPA suppresses adiponectin and the receptors involved remains to be determined.